Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

11.85
Delayed Data
As of Jan 13
 +0.10 / +0.85%
Today’s Change
6.00
Today|||52-Week Range
13.45
-2.47%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close11.75
Today’s open11.90
Day’s range11.77 - 12.25
Volume195,278
Average volume (3 months)342,622
Market cap$480.1M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)+77.32%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book6.84

Competitors

 Today’s
change
Today’s
% change
COLLCollegium Pharmaceut...+0.32+2.00%
HRTXHeron Therapeutics I...0.000.00%
OTICOtonomy Inc+0.15+0.90%
CRHMCRH Medical Corp0.000.00%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs